Recent Posts



  • There is no value or strategy. The only thing they bring is their ego

anonymous
Jul 17, 2025 at 01:40 PM
  • The issue is all the fantastic generic medicines and more added each year. It is going to be harder and harder for pharmaceutical research to replace income for medicines that went generic. Companies are going to have to take bigger and bigger risks. Market size will be smaller and companies will have to charge $100,000s per year to replace income stream. For years, PhD researchers have made less money than business leaders in pharma. University pharmaceutical research is way down because of lack of government research grants. Why would anyone get a PhD in pharmacology today?

anonymous
Jul 17, 2025 at 01:35 PM
  • Track record for BI spec products has not been good recently. See above with Cyltezo and Spevigo.

    Then letting Al M go unceremoniously was another dipshit move by Sr leaders. Guy was a great leader and the OFEV reps loved him. Good luck launching Nerando.

anonymous
Jul 17, 2025 at 01:29 PM
  • Thanks for your comments Brady. You are full of shit!
    Nope. It’s actually true. Reps ask for everything and the company just sucks it up and makes it. Then maybe 5% use it and the rest of the company just whine
    Wah….i can’t pull it through….wah.’ Bunch of little bitches.

anonymous
Jul 17, 2025 at 01:26 PM